ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 925

Abortive Viral Infection Becomes Macrophage Activation Syndrome in Mice with Chronically Elevated Interleukin-18: Evidence for Synergy with Cytotoxic Impairment

Paul Tsoukas1, Corinne Schneider2, Lauren Van Der Kraak2 and Scott Canna3, 1Pediatric Rheumatology, Children’s Hospital of Pittsburgh, Pittsburgh, PA, 2RK Mellon Institute for Pediatric Research, University of Pittsburgh/Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 3RK Mellon Institute for Pediatric Research, University of Pittsburgh/Children's Hospital of Pittsburgh of UPMC, Pittsburrgh, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Autoinflammation, IL-1/IL-18, Systemic JIA and macrophage activation syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S106 ACR Abstract: Pediatric Rheumatology–Basic Science (922–927)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Macrophage Activation Syndrome (MAS) and Hemophagocytic lymphohistiocytosis (HLH) are clinically similar life-threatening hyperinflammatory syndromes, often triggered by viral infection. HLH is associated with cytotoxic impairment (e.g. Perforin deficiency). The causes of MAS remain unknown, but both cytotoxic impairment and elevated Interleukin (IL)-18 may contribute.

Methods: Mice were infected with the typically self-limiting LCMV-Armstrong virus, and assessed for systemic inflammation, serum cytokines, antigen-specific responses, and viral clearance.

Results: Whereas LCMV-infected WT mice developed no outward inflammation, Il18tg mice developed features of MAS (weight loss, splenomegaly, cytopenias, transaminitis, cytokinemia) nearly as severe as Prf1-/- (Fig 1A). Unlike Prf1-/-, Il18tg mice had no appreciable impairment in viral clearance and showed normal upregulation of cytotoxic proteins. Consistent with their systemic hyperinflammatory phenotype, Il18tg mice had a larger effector CD8 T-cells response than WT.

Unexpectedly, mice with both hyperinflammatory susceptibility factors (Prf1-/-;Il18tg mice) were born in Mendelian ratios but quickly developed a spontaneous inflammatory phenotype characterized by weight loss, cytopenias, cytokinemia and hepatosplenomegaly (Fig 1B). Prf1-/-;Il18tg mice have a concomitant increase in splenic myeloid and activated CD-8 T cells, all consistent with a spontaneous MAS-like phenotype.

Conclusion: Chronic IL-18 promotes systemic hyperinflammation despite apparently normal viral clearance during LCMV infection, consistent with MAS. Spontaneous MAS in Prf1-/-;Il18tg demonstrates the complementary and non-redundant nature of these mechanisms. It also indicates a homeostatic immunoregulatory function for Perforin. Our data suggest clinical assessment of both pathways could improve targeted treatment in these life-threatening hyperinflammatory disorders.

 


Disclosure: P. Tsoukas, None; C. Schneider, None; L. Van Der Kraak, None; S. Canna, AB2 Bio, Ltd, 5.

To cite this abstract in AMA style:

Tsoukas P, Schneider C, Van Der Kraak L, Canna S. Abortive Viral Infection Becomes Macrophage Activation Syndrome in Mice with Chronically Elevated Interleukin-18: Evidence for Synergy with Cytotoxic Impairment [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/abortive-viral-infection-becomes-macrophage-activation-syndrome-in-mice-with-chronically-elevated-interleukin-18-evidence-for-synergy-with-cytotoxic-impairment/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abortive-viral-infection-becomes-macrophage-activation-syndrome-in-mice-with-chronically-elevated-interleukin-18-evidence-for-synergy-with-cytotoxic-impairment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology